1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride

Base Information

• Chemical Name: 1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride
• CAS No.: 80185-65-5
• Molecular Formula: C26H29 F N2 O2 . Cl H
• Molecular Weight: 456.9800032
• European Community (EC) Number: 279-414-0,635-977-8
• DSSTox Substance ID: DTXSID001001081
• Mol file: 80185-65-5.mol

Synonyms:1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid;Bilina;lévophta;levocabastine;levocabastine hydrochloride;levophta;livocab;livostin

Chemical Property of 1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid monohydrochloride

Chemical Property:

• Vapor Pressure: 9.28E-15mmHg at 25°C
• Boiling Point: 589.9°C at 760 mmHg
• Flash Point: 310.5°C
• PSA: 64.33000
• LogP: 5.63398
• Hydrogen Bond Donor Count: 2
• Hydrogen Bond Acceptor Count: 5
• Rotatable Bond Count: 4
• Exact Mass: 456.1979841
• Heavy Atom Count: 32
• Complexity: 681

Purity/Quality:

99% ^*data from raw suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F.Cl
• Recent EU Clinical Trials: A randomised, double-blind, placebo-controlled, 3 way, incomplete block cross over study in subjects with allergic rhinitis to assess the effect of once daily single and repeat doses of intranasal Fluticasone furoate/Levocabastine fixed dose combination (FDC) relative to Levocabastine and Fluticasone furoate alone on the onset and magnitude of symptoms of rhinitis in an allergen challenge chamber